Ellen Schlichting

3.0k citations
55 papers · 2.2k · h-index 23

Impact in

    • Breast Cancer Treatment Studies
    • Cancer Genomics and Diagnostics
  • Oncology top 5%
    • Cancer Cells and Metastasis
    • Bone health and treatments

Papers in

    • Breast Cancer Treatment Studies 10
    • Cancer Genomics and Diagnostics 7
    • BRCA gene mutations in cancer 9
    • Estrogen and related hormone effects 2
    • Genomic variations and chromosomal abnormalities 2

Ellen Schlichting

55 papers receiving 2.2k citations

Peers

Ellen Schlichting
Comparison fields: 5 of 101
  • Cancer Research 799
  • Oncology 688
  • Genetics 435
  • Pathology and Forensic Medicine 175
  • Orthopedics and Sports Medicine 71
Replace M. Stierer with:
M. Stierer Austria
Susanne Taucher Austria
JØRN ERIK ANDERSEN Denmark
Michela Donadio Italy
Miwa Yoshida Japan
Jacques Bonneterre France
Eduardo R. Pajon United States
Patrick Berteloot Belgium
B. Massidda Italy
Yasuo Hozumi Japan
Ellen Schlichting relative to M. Stierer Austria M. Stierer's profile →
Citations per field
00.5×2×3×4×4.8×
M. Stierer · 1×
Citations per year

Countries citing papers authored by Ellen Schlichting

Since Specialization
Citations

This map shows the geographic impact of Ellen Schlichting's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ellen Schlichting with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ellen Schlichting more than expected).

Fields of papers citing papers by Ellen Schlichting

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ellen Schlichting. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ellen Schlichting. The network helps show where Ellen Schlichting may publish in the future.

Co-authors

The 25 scholars most cited alongside Ellen Schlichting, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ellen Schlichting Line = papers co-authored together Ellen Schlichting links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 55 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2005244
2 2003242
3 2015126
4 1998119
5 2010119
6 2021116
7 2010115
8 201794
9 200688
10 201682
11 201777
12 202046
13 202042
14 201439
15 201735
16 201234
17 201934
18 201834
19 201634
20 200833

About Ellen Schlichting

Ellen Schlichting is a scholar working on Cancer Research, Genetics, Oncology, Endocrinology, Diabetes and Metabolism and Pathology and Forensic Medicine, having authored 55 papers that have together received 2.2k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (10 papers), BRCA gene mutations in cancer (9 papers), Cancer Genomics and Diagnostics (7 papers), Blood Coagulation and Thrombosis Mechanisms (3 papers), Cancer Risks and Factors (3 papers), Estrogen and related hormone effects (2 papers), Renal function and acid-base balance (2 papers) and Genomic variations and chromosomal abnormalities (2 papers). The work is most often cited by research in Cancer Research (799 citations), Oncology (688 citations), Genetics (435 citations), Pathology and Forensic Medicine (175 citations) and Orthopedics and Sports Medicine (71 citations). Ellen Schlichting has collaborated with scholars based in Norway, United States and Germany. Frequent co-authors include Rolf Kåresen, Elin Borgen, Jan Franz Nygård, Bjørn Naume, Anne Irene Hagen, Gro Wiedswang, Torill Sauer, Lars Erik Krag, Anna Polli and Erik Snorre Øfjord. Their work appears in journals such as Scientific Reports, Breast Cancer Research, Journal of Clinical Oncology, BMC Cancer and Molecular Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact